IGBA, the International Generic and Biosimilar medicines Association, representing global manufacturers of generic and biosimilar medicines, announced today that the Cámara Industrial de Laboratorios Farmacéuticos Argentinos (CILFA) has been accepted and welcomed as a new IGBA Associate Member.
“The International Generic and Biosimilar medicines Association (IGBA) invites generic and biosimilar medicines manufacturers to actively engage and commit to contributing to the global manufacturing capacity once an existing or newly-discovered therapeutic is proven to be effective against COVID-19.
IGBA, the International Generic and Biosimilar medicines Association (IGBA), representing global manufacturers of generic and biosimilar medicines, today pays tribute to Bill Haddadi, who passed away last week. He was a pioneer in the development of generic medicine policy in the U.S.A. and a remarkable advocate for access to medicines worldwide.
IGBA | INTERNATIONAL GENERIC AND BIOSIMILAR MEDICINES ASSOCIATION
C/O DYN SA
Rue de Cornavin 11
1201 Geneva, Switzerland
Telephone: +32 (0)2 5346607 (S. Kox)
E-mails:
This email address is being protected from spambots. You need JavaScript enabled to view it.
or
Secretary General –
This email address is being protected from spambots. You need JavaScript enabled to view it.